The Hidden War on Hemp: Who Benefits from the Ban?
2 views2:27
Explore the critical discussion around the current administration's stance on hemp, which groups all varieties, from oral supplements to CBD and CBDA, as 'bad.' This controversial approach has sparked debate over individual freedom and the lack of distinction between different compounds.
Learn why the speaker argues against this blanket outlawing, particularly highlighting the proven efficacy of CBDA as an anti-seizure supplement and for pain control. The failure to differentiate between industrial products and therapeutic compounds like CBDA raises serious questions about public policy and access to natural health solutions.
Subscribe to the BrightVideos.com email newsletter to receive a daily digest of the most important and popular videos uploaded each day. (You can unsubscribe at any time.)
Transcript
That's what freedom is supposed to be all about. And, you know, here we are in a country right now that where the administration is at war with all varieties of hemp. And they've made no distinction between the oral supplements, the gummies or even just CBD or CBDA. And I know many people who use CBDA as an anti-seizure supplement. By the way, it's very effective for many people. And also pain control, anti-inflammatory things like that. But there's no distinction in the administration. They just say all hemp is bad and all hemp needs to be completely outlawed. What's wrong with that grouping all in the same basket in your view? Well, the the initial problem is that you eliminate choice and options from the market. And I will tell you that having been involved in this fight for many years, there are several interests, meaning industries that do not want to see the natural products category expanded through hemp. It does not serve them, it doesn't make them money. They want a captured audience and that goes all the way from alcohol, pharma to actually marijuana companies. All looking to get rid of this alternative. So that's ...
